American Express (NYSE:AXP) Receives Average Recommendation of “Hold” from Analysts

Share on StockTwits

American Express (NYSE:AXP) has been assigned a consensus rating of “Hold” from the nineteen analysts that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and ten have given a buy recommendation to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $123.23.

A number of equities research analysts have recently weighed in on AXP shares. UBS Group started coverage on shares of Molecular Templates in a research report on Monday, April 29th. They issued a “buy” rating and a $12.00 price target for the company. Stephens set a $131.00 target price on shares of American Express and gave the stock a “buy” rating in a research note on Monday, May 20th. Royal Bank of Canada set a $60.00 target price on shares of Masonite International and gave the stock a “buy” rating in a research note on Friday, May 3rd. Bank of America reduced their price objective on shares of Canopy Growth from $80.00 to $75.00 and set a “buy” rating on the stock in a research note on Wednesday, June 19th. Finally, Oppenheimer set a $119.00 price objective on shares of American Express and gave the stock a “buy” rating in a research note on Wednesday, April 17th.

American Express stock traded down $3.58 during mid-day trading on Friday, hitting $124.82. 7,814,122 shares of the company’s stock were exchanged, compared to its average volume of 2,890,161. The firm has a market capitalization of $107.22 billion, a price-to-earnings ratio of 17.03, a P/E/G ratio of 1.48 and a beta of 1.07. American Express has a fifty-two week low of $89.05 and a fifty-two week high of $129.34. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 2.63. The company has a 50 day moving average price of $123.42.

American Express (NYSE:AXP) last released its earnings results on Friday, July 19th. The payment services company reported $2.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.05 by $0.02. The firm had revenue of $10.84 billion during the quarter, compared to analysts’ expectations of $10.82 billion. American Express had a return on equity of 29.86% and a net margin of 16.60%. The company’s revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.84 EPS. On average, sell-side analysts anticipate that American Express will post 8.12 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 5th will be given a dividend of $0.39 per share. The ex-dividend date is Wednesday, July 3rd. This represents a $1.56 dividend on an annualized basis and a yield of 1.25%. American Express’s dividend payout ratio (DPR) is currently 21.28%.

In other American Express news, CFO Jeffrey C. Campbell sold 6,500 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $122.93, for a total value of $799,045.00. Following the completion of the transaction, the chief financial officer now directly owns 68,379 shares in the company, valued at $8,405,830.47. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Michael John O’neill sold 15,749 shares of the business’s stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $113.94, for a total transaction of $1,794,441.06. Following the completion of the transaction, the insider now directly owns 69,941 shares in the company, valued at approximately $7,969,077.54. The disclosure for this sale can be found here. Over the last three months, insiders have sold 183,797 shares of company stock valued at $21,861,060. 0.21% of the stock is currently owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in AXP. Comerica Securities Inc. raised its stake in shares of American Express by 5.3% during the fourth quarter. Comerica Securities Inc. now owns 5,582 shares of the payment services company’s stock worth $532,000 after purchasing an additional 279 shares during the last quarter. Bessemer Group Inc. boosted its stake in American Express by 1.4% in the 4th quarter. Bessemer Group Inc. now owns 9,867 shares of the payment services company’s stock worth $940,000 after buying an additional 136 shares during the last quarter. Gideon Capital Advisors Inc. acquired a new stake in American Express in the 4th quarter worth about $353,000. Epoch Investment Partners Inc. boosted its stake in American Express by 2.6% in the 4th quarter. Epoch Investment Partners Inc. now owns 53,747 shares of the payment services company’s stock worth $5,123,000 after buying an additional 1,355 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in American Express by 5.7% in the 4th quarter. Geode Capital Management LLC now owns 8,486,121 shares of the payment services company’s stock worth $807,358,000 after buying an additional 459,983 shares during the last quarter. 83.60% of the stock is currently owned by institutional investors.

American Express Company Profile

American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services to consumers and businesses worldwide. It operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services.

Featured Article: What is a recession?

Analyst Recommendations for American Express (NYSE:AXP)

Receive News & Ratings for American Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Express and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.